These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17655957)

  • 41. Two new colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus.
    Coban AY; Bozdogan B; Cihan CC; Cetinkaya E; Bilgin K; Darka O; Akgunes A; Durupinar B; Appelbaum PC
    J Clin Microbiol; 2006 Feb; 44(2):580-2. PubMed ID: 16455915
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
    Park YS; Shin WS; Kim SK
    J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro susceptibility of clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) to manufactured generic drugs compared with the brand vancomycin.
    Fujimura S; Watanabe A; Fuse K; Kikuchi T; Gomi K; Tokue Y
    Int J Antimicrob Agents; 2008 Apr; 31(4):391-2. PubMed ID: 18308516
    [No Abstract]   [Full Text] [Related]  

  • 45. Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities.
    Niebuhr M; Mai U; Kapp A; Werfel T
    Exp Dermatol; 2008 Nov; 17(11):953-7. PubMed ID: 18557929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Staphylococcus aureus with reduced susceptibility to vancomycin.
    Cosgrove SE; Carroll KC; Perl TM
    Clin Infect Dis; 2004 Aug; 39(4):539-45. PubMed ID: 15356818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus.
    Tsuji BT; Rybak MJ; Lau KL; Sakoulas G
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1089-91. PubMed ID: 17158941
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activity of blue green microalgae extracts against in vitro generated Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhateja P; Mathur T; Pandya M; Fatma T; Rattan A
    Fitoterapia; 2006 Apr; 77(3):233-5. PubMed ID: 16556488
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antibiotic sensitivity of S. aureus strains isolated from meningeal infections].
    Fedulov D; Mihalache DG
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):125-8. PubMed ID: 19326725
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus.
    Wootton M; Walsh TR; MacGowan AP
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3982-3. PubMed ID: 16127089
    [No Abstract]   [Full Text] [Related]  

  • 51. [Short communication: Determination of methicillin resistance in staphylococci with different methods and detection of multiple antibiotic resistance].
    Cetinkol Y; Altindiş M; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2008 Jan; 42(1):119-24. PubMed ID: 18444569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unacceptable performance and the lack of reproducibility results in the report of colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus.
    Acuner IC; Eroglu C
    J Clin Microbiol; 2006 Jun; 44(6):2318-9; author reply 2319. PubMed ID: 16757653
    [No Abstract]   [Full Text] [Related]  

  • 53. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany.
    Bierbaum G; Fuchs K; Lenz W; Szekat C; Sahl HG
    Eur J Clin Microbiol Infect Dis; 1999 Oct; 18(10):691-6. PubMed ID: 10584894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
    Tillotson GS; Draghi DC; Sahm DF; Tomfohrde KM; Del Fabro T; Critchley IA
    J Antimicrob Chemother; 2008 Jul; 62(1):109-15. PubMed ID: 18397923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lysogenic conversion as a factor influencing tolerance to vancomycin in Staphylococcus aureus].
    Młynarczyk G; Młynarczyk A; Zabicka D; Jeljaszewicz J
    Med Dosw Mikrobiol; 1997; 49(1-2):13-7. PubMed ID: 9411067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of daptomycin against Staphylococcus aureus and vancomycin-resistant Enterococcus faecium isolates associated with skin and soft tissue infections: first results from India.
    Dhawan B; Gadepalli R; Kapil A
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):196-8. PubMed ID: 19748433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization.
    Kedzierska A; Kapińska-Mrowiecka M; Czubak-Macugowska M; Wójcik K; Kedzierska J
    Br J Dermatol; 2008 Dec; 159(6):1290-9. PubMed ID: 18795934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surveillance of antibacterial resistance in Staphylococcus aureus isolated in Kuwaiti hospitals.
    Udo EE; Al-Sweih N; Dhar R; Dimitrov TS; Mokaddas EM; Johny M; Al-Obaid IA; Gomaa HH; Mobasher LA; Rotimi VO; Al-Asar A
    Med Princ Pract; 2008; 17(1):71-5. PubMed ID: 18059105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.